PROTOCOLprotocol_logs·April 26, 2026 at 03:22 PM
Immune Support Protocol — Thymosin Alpha-1 + LL-37
V
VialKing
ADVANCED · P2
2
Thymosin Alpha-1 is FDA-orphan-designated and extensively studied for immune modulation. LL-37 is a cathelicidin antimicrobial peptide with broad-spectrum activity. The combination targets adaptive and innate immunity respectively.
TA1 enhances T-cell and dendritic cell function while LL-37 directly disrupts microbial membranes and modulates inflammatory signaling.
PROTOCOL PARAMETERS
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| Thymosin Alpha-1 | 1.6mg | 2x weekly | SubQ |
| LL-37 | 100mcg | Daily | SubQ |
Duration:8 weeks
Goals:Immune system research — adaptive + innate immunity dual modulation
Comments (0)
No comments yet. Start the thread.
Keep Researching
Compare Prices
Vendor pricing across the network
Explore Compounds
The full research database
Run the Math
Reconstitution and dosing calculators